- Home
- CNK vs VCYT Comparison
CNK vs VCYT Comparison
Compare CNK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNK | VCYT |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2007 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CNK | VCYT |
|---|---|---|
| Price | $23.87 | $43.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $35.30 | ★ $45.38 |
| AVG Volume (30 Days) | ★ 4.4M | 1.0M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.11 | 0.38 |
| Revenue | ★ $3,153,000,000.00 | $495,141,000.00 |
| Revenue This Year | $6.71 | $16.02 |
| Revenue Next Year | $7.78 | $10.74 |
| P/E Ratio | ★ $22.14 | $112.61 |
| Revenue Growth | 9.70 | ★ 16.41 |
| 52 Week Low | $21.62 | $22.61 |
| 52 Week High | $34.01 | $50.71 |
Technical Indicators
Market Signals| Indicator | CNK | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 52.11 |
| Support Level | $21.62 | $41.55 |
| Resistance Level | $25.57 | $45.17 |
| Average True Range (ATR) | 1.26 | 1.80 |
| MACD | -0.19 | -0.67 |
| Stochastic Oscillator | 32.80 | 21.94 |
Price Performance
Historical ComparisonAbout CNK Cinemark Holdings Inc Cinemark Holdings Inc.
Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.